Clinical Trials Directory

Trials / Completed

CompletedNCT00852813

Tolerance and Prebiotic Activity of Arabinoxylan-Oligosaccharides in Healthy Subjects

Tolerance and Prebiotic Activity of Arabinoxylan-Oligosaccharides in Healthy Subjects: a Randomized, Placebo-Controlled Cross-Over Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
20 (actual)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to evaluate the tolerance of a higher dose of arabinoxylan-oligosaccharides (AXOS) and their prebiotic activity in healthy subjects.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTarabinoxylan-oligosaccharides (AXOS)intake period: 3 weeks, 10 g/day

Timeline

Start date
2007-10-01
Completion
2008-06-01
First posted
2009-02-27
Last updated
2009-02-27

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00852813. Inclusion in this directory is not an endorsement.